(NASDAQ: ANIX) Anixa Biosciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 37.26%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 41%.
Anixa Biosciences's earnings in 2025 is -$11,115,000.On average, 6 Wall Street analysts forecast ANIX's earnings for 2025 to be -$11,751,339, with the lowest ANIX earnings forecast at -$11,290,502, and the highest ANIX earnings forecast at -$12,096,966. On average, 6 Wall Street analysts forecast ANIX's earnings for 2026 to be -$11,191,751, with the lowest ANIX earnings forecast at -$12,258,259, and the highest ANIX earnings forecast at -$8,295,063.
In 2027, ANIX is forecast to generate -$10,072,576 in earnings, with the lowest earnings forecast at -$11,613,088 and the highest earnings forecast at -$8,295,063.